NCT02075268View on ClinicalTrials.gov

Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy
Interventions
DRUG

prasugrel

prausugrel 10 or 30 mg will be administrated as single dose under overnight fast.

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02075268 - Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers | Biotech Hunter | Biotech Hunter